Endoscopic stenting of the common bile duct allows successful treatment of a breast cancer patient with excessive liver metastases

Am J Clin Oncol. 2004 Dec;27(6):642-3. doi: 10.1097/01.coc.0000147427.30984.f7.

Abstract

The treatment of a jaundiced patient with hyperbilirubinaemia due to breast cancer liver metastases is still a challenging problem. The associated hepatic dysfunction often represents a limiting factor for delivering standard dose chemotherapy. We report on the successful treatment of a jaundiced patient with excessive, recurrent liver metastases from breast cancer, using a combined chemotherapy of mitomycin and 5-fluorouracil after endoscopic stenting of the common bile duct.

Publication types

  • Case Reports

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Breast Neoplasms / pathology*
  • Combined Modality Therapy
  • Common Bile Duct* / pathology
  • Common Bile Duct* / surgery
  • Constriction, Pathologic / surgery
  • Endoscopy
  • Female
  • Fluorouracil / administration & dosage
  • Humans
  • Hyperbilirubinemia / etiology
  • Hyperbilirubinemia / surgery
  • Liver Neoplasms / complications
  • Liver Neoplasms / secondary*
  • Liver Neoplasms / therapy*
  • Middle Aged
  • Mitomycin / administration & dosage
  • Palliative Care*
  • Stents*

Substances

  • Mitomycin
  • Fluorouracil